湿热痹片治疗湿热痹阻型骨关节炎的临床观察

目的观察湿热痹片对湿热痹阻型骨关节炎的疗效。方法将40例湿热痹阻型膝骨关节炎患者分为治疗组(20例)、对照Ⅰ组(10例)和对照Ⅱ组(10例),分别给予湿热痹片、非甾体药物(扶他林或英太青片)、湿热痹片合非甾体药物口服治疗,观察其总有效率及临床指标的改善情况。结果 总有效率比较:治疗组的总有效率为85%,三组的差异无统计学意义(P>0.05)。治疗前后主要临床症状积分比较:治疗前,三组的差异无统计学意义(P>0.05)。2周、5周、8周后,与同组治疗前比较,均有统计学意义(P<0.01)。8周后,治疗组与对照Ⅰ组比较,无统计学意义(P>0.05),与对照Ⅱ组比较,有统计学意义(P<0.01)。治疗前后血沉比较:治疗前,三组差异无统计学意义(P>0.05)。8周后,与同组治疗前比较,明显降低,均有统计学意义(P<0.01),治疗组与对照Ⅰ组、对照Ⅱ组比较,无统计学意义(P>0.05)。结论 湿热痹片治疗湿热痹阻型骨关节炎是安全有效的,与非甾体药物合用不仅能增强疗效,而且还可减少副反应,具有较好的临床运用价值。     

MEBO配合散瘀消肿汤薰洗治疗膝关节创伤性滑膜炎的对比分析

目的：观察MEBO配合散瘀消肿汤治疗膝关节创伤性滑膜炎的疗效。方法：采用数字表法将120例患者随机分为治疗组60例和对照组60例。治疗组使用MEBO配合散瘀消肿汤治疗,对照组采用双氯芬酸二乙胺乳胶剂配合散瘀消肿汤的治疗。结果：两组总有效率P〈0．01,差异具有非常显著性意义;两组七日内止痛、消肿疗效对比P〈0．01,其差异亦具有非常显著性意义。两组各证型间疗效对比,气滞血瘀型、风寒湿阻型、痰湿结滞型等均P〈0．05,差异具有显著性意义,而脾肾不足型P〉0．05,差异无显著性意义。结论：MEBO配合散瘀消肿汤薰洗治疗膝关节创伤性滑膜炎具有显著的疗效,其疗效明显优于对照组,值得临床推广应用。     

汗停汤治疗肺癌患者多汗症60例临床观察

目的 探讨中药汗停汤治疗晚期肺癌患者多汗症的临床疗效.方法 120例肺癌并多汗症患者随机分为治疗组与对照组各60例,分别给予中药汗停汤和西药谷维素治疗,观察止汗效果.结果 治疗组总有效率81.67%,对照组总有效率58.33%,两组疗效比较有显著性差异(P＜0.01).结论 中药汗停汤治疗肺癌多汗症疗效较好,值得进一步研究.     

银蒲消癥汤保留灌肠联合超短波治疗湿热瘀结型盆腔炎性包块161例临床观察

目的:观察银蒲消癥汤保留灌肠联合超短波对湿热瘀结型盆腔炎性包块的临床疗效.方法:选取湿热瘀结型盆腔炎性包块患者81例,随机分为两组.治疗组41例,采用银蒲消癥汤保留灌肠联合超短波治疗;对照组40例,采用康妇消炎栓联合超短波治疗.15 d为1疗程,共2个疗程.观察两组患者临床症状、体征、盆腔B超的变化,以及停药3个月后的复发率.结果:治疗组患者1个疗程、2个疗程后愈显率和总有效率均高于对照组,有显著性差异(P<0.05).2个疗程后B超检查附件区包块均较治疗前明显缩小,两组间差值比较有显著性差异(P<0.05),治疗组在包块大小改善情况优于对照组.停药3个月后治疗组无复发,对照组复发率为7.5%.结论:银蒲消癥汤保留灌肠联合超短波能明显改善湿热瘀结型盆腔炎性包块的各种症状和体征,并能使超声观察下盆腔炎性包块在短期内消失或明显缩小,且复发率低,疗效明显优于康妇消炎栓联合超短波治疗.     

厄贝沙坦片和厄贝沙坦氢氯噻嗪片治疗轻中度高血压病疗效观察

目的比较厄贝沙坦片和厄贝沙坦氢氯噻嗪片对轻中度高血压患者的降压疗效。方法将80例轻中度高血压患者随机分为厄贝沙坦片治疗组（n=40）和厄贝沙坦氢氯噻嗪片治疗组（n=40）。结果治疗第8周时厄贝沙坦片治疗组和厄贝沙坦氢氯噻嗪片治疗组有效率分别为85%、90%（P〉0.05）。两组收缩压及舒张压均显著降低,两组间降压程度无显著性差异。结论两种药物均能有效降低血压。     

青蒿对RA患者外周血和滑膜细胞TNF-α、IL-6水平的影响

目的 观察中药青蒿对类风湿关节炎(RA)患者外周血和滑膜细胞培养液TNF-α、IL-6水平的影响,探讨青蒿治疗RA的免疫机制.方法 (1)入选50例活动性RA患者,随机分为两组,对照组口服甲氨蝶呤(MTX)10 mg,1次/w.治疗组服中药青蒿20 g,1剂/d;MTX 10 mg,1次/w.两组疗程均为12 w.用ELISA法检测两组治疗前后血清TNF-α、IL-6水平.(2)收集25例活动性RA患者关节液标本,体外分离培养滑膜细胞,以生长良好的3～5代滑膜细胞进行实验,分为对照组、青蒿琥酯(ART)12.5 μg/ml组、MTX 20 μg/ml组、ART + MTX组.结果 (1)两组RA患者血清IL-6水平均较治疗前显著降低(P＜0.05);治疗后治疗组TNF-α水平较治疗前降低(P＜0.05),对照组TNF-α水平虽较治疗前降低,但差异无显著性(P＞0.05),治疗后治疗组的TNF-α水平较对照组显著降低(P＜0.05);治疗后两组IL-6水平无显著差异(P＞0.05);(2)RA患者滑膜细胞IL-6、TNF-α水平变化:ART 12.5 μg/ml、MTX 20 μg/ml及两种药物的混合液分别处理滑膜细胞48 h后,培养上清液中TNF-α、IL-6水平均较对照组降低(P＜0.05);组间比较,ART与MTX联合应用较单用一种药物能更显著降低细胞因子水平(P＜0.05).结论 青蒿能明显降低RA患者的TNF-α、IL-6水平,这可能是青蒿治疗RA的作用机制之一.     

中西医治疗军人胆汁反流性胃炎的临床观察

目的探讨中西医结合治疗军人胆汁反流性胃炎的临床疗效。方法以我院2008年1月至2013年10月间收治的132例南方某部队军人胆汁反流性胃炎为研究对象,随机分为治疗组(70例)和对照组(62例)。治疗组采用西药(多潘立酮、铝碳酸镁和枸橼酸铋钾)联合中药(胃特安片)疗法,对照组采用单纯西药治疗。疗程结束后,比较分析两组患者临床总的疗效、胃镜下改善程度、幽门螺旋杆菌(HP)根除率以及组织病理学改变。结果治疗组临床总的疗效有效率为100%,明显高于对照组的90.3%(P<0.01);治疗组胃镜下疗效有效率为92.9%,显著高于对照组的75.8%(P<0.01);治疗组HP根除率(95.5%)与对照组(88.9%)比较,差异无统计学意义(P>0.05);两组活动性炎症均取得较好疗效,无明显差异(P>0.05);治疗组胃黏膜腺体萎缩、肠上皮化生、不典型增生等病理学改善有效率为91.7%,显著高于对照组的72.5%(P<0.05)。结论西药联合中药(胃特安片)治疗军人胆汁反流性胃炎,其疗效优于单纯西药治疗。     

激光加综合治疗对慢性湿疹的疗效观察

目的：探讨激光加综合治疗对慢性湿疹的疗效。方法：选择109例门诊患者，分为试验组54例，对照组55例，两组患者口服阿司咪唑9mg，1次／d。试验组：（1）先用SUNDDOM－300IB型半导体激光治疗机照射病变部位及相应的穴位；（2）放松训练；（3）支持性心理治疗。比较两组疗程、疗效。结果：两组在第1、2w有效率相似，差异无显著性（P〉0．05），第3、4w两组临床症状比较差异有显著性（P〈O．05），从第3w开始，两组的有效率之问差异有显著性（P〈0．05）。试验组在治疗3w后疗效明显高于对照组。治疗3个月后临床有效率比较差异显著（P〈0．05）。结论：激光加综合治疗可提高慢性湿疹的疗效。     

彩色多普勒超声对中药治疗慢性充血性心力衰竭疗效的分析

目的 :运用彩色多普勒超声技术监测中药治疗慢性充血性心力衰竭前后心功能变化的情况。方法 :选取择慢性心功能不全病人 4 0例 ,均经超声或临床确诊。随机分为中药组 2 0例与西药组 2 0例 ,分别用中药及西医正规治疗 ,观测其心功能各项参数EFFS治疗前后的变化。结果 :射血分数 (EF)及左室短轴缩短率 (FS)不论在中药组还是西药组 ,第2 / 6 / 10周的测量值都有统计学差异 ;中药组和西药组的治疗前后总测量值比较有统计学差异 ,P =0 0 10 ;EF指标的第 2 /6 / 10周的变化趋势在中药组和西药组两组间是不同的 ,差异有统计学意义 ,P =0 0 10。结论 :中药组及西药组二者均能有效改善心功能 ;但西药疗效快 ,长期疗效欠佳 ,中药疗效慢 ,但长期疗效持久稳定 ;指标EF较FS更敏感。     

盐酸氨基葡萄糖片治疗颞颌关节炎疗效分析

目的探讨盐酸氨基葡萄糖片治疗颞颌关节炎的临床疗效。方法回顾性分析自2013年1月至2015年5月在宜宾市三医院治疗的颞颌关节炎患者120例的临床资料。其中,60例患者给予常规治疗设为A组,60例患者在常规治疗基础上给予盐酸氨基葡萄糖片设为B组。比较两组患者的最大张口度、视觉模拟评分(VAS)及张口偏斜程度。结果两组患者治疗第2周,最大张口度均升高,高于治疗前(P<0.01);在治疗第3、4周,B组的最大张口度显著升高,高于A组,组间比较,差异有统计学意义(P<0.01)。在治疗第2、3、4周,B组的张口疼痛VAS评分、张口偏斜程度均显著低于A组,组间比较,差异均有统计学意义(P<0.01)。结论在常规治疗基础上给予盐酸氨基葡萄糖片治疗颞颌关节炎,能够提高临床疗效,值得推广应用。     

The low energy X-ray response of the LiF:Mg:Cu:P thermoluminescent dosemeter: a comparison with LiF:Mg:Ti

LiF:Mg:Cu:P thermoluminescent dosemeters (TLD) can be used for the same X-ray dosimetry applications as LiF:Mg:Ti, with each type having the disadvantage of a response dependent on energy, particularly at low energies. Measurements were made of the response per unit air kerma of LiF:Mg:Cu:P and LiF:Mg:Ti to nine quasi-monoenergetic X-ray beams with mean energies from 12 keV to 208 keV. Each measurement was normalized to the value produced by 6 MV X-rays. LiF:Mg:Cu:P was found to under-respond to a majority of these radiations whereas LiF:Mg:Ti over-responded to a majority. Their smallest relative measured response was produced by the lowest energy beam, and the maximum measured relative response of 1.15+/-0.07 and 1.21+/-0.07 for LiF:Mg:Cu:P and LiF:Mg:Ti, respectively, occurred at 33 keV. Energy response coefficients were derived from these measurements to estimate the error introduced by using either type of TLD to measure the dose from an X-ray spectrum different to that used for its absolute response calibration. It was calculated that if the response of either type of TLD was calibrated at 100 kVp, then an error of no more than +/-2% would be introduced into measurements of tube output at potentials of 50-130 kVp. LiF:Mg:Cu:P was found to introduce a larger error (up to 30%) into the measurement of body exit dose than LiF:Mg:Ti at tube potentials of 40-150 kVp, if its absolute response was calibrated using the corresponding body entrance beam. The method should allow this type of error to be estimated in other dosimetry applications for either type of TLD.     

Introduction: economy of running: a multidisciplinary perspective.

This symposium endeavors to address the issue of running economy from a multidisciplinary perspective. Topics addressed in this symposium include physiological aspects of running economy, changes in running economy with age during childhood and adolescence, biomechanical considerations for economical walking and running, psychological state and running economy, and running economy of elite performers. While the knowledge base in this area is expanding, future research should emphasize the formulation of testable hypotheses and the fostering of collaborative efforts aimed at identifying and manipulating variables associated with improved economy and discovering mechanisms underlying economical running styles.     

Vascular Complications of Transplantation: Part 2: Pancreatic Transplants

Vascular complications after solid organ transplantation are not uncommon and may lead to graft dysfunction and ultimately graft loss. A thorough understanding of the surgical anatomy, etiologies, and types of vascular complications, their presentation and the options for management are important for managing these complex patients. This article reviews the basic surgical anatomy, the vascular complications, and endovascular management options of vascular complications in patients with pancreas transplants.     

Percutaneous Biliary Interventions: Inside and Outside the Box: Gallbladder: Role of Interventional Radiology

Percutaneous cholecystostomy is an established procedure for the management of patients with acute cholecystitis and with significant medical comorbidities that would make laparoscopic cholecystectomy excessively risky. In this review, we will explore the role of percutaneous cholecystostomy in the management of acute cholecystitis as well as other applications in the management of biliary pathology. The indications, grading, technical considerations, and postprocedure management in the setting of acute cholecystitis are discussed. In addition, we will discuss the potential role of percutaneous cholecystostomy in the management of gallstones and biliary strictures, in establishing internal biliary drainage, and in a joint setting with other clinicians such as gastroenterologists in the management of complex biliary pathology.